Liraglutide-induced pancreatitis: a case report and literature review
30 Notably, 18% of patients had a prior LVEF 40, and 42% had undocumented LVEF
Patients that maintained treatment response for 2 weeks at the end of the open label treatment period were eligible to be randomized to ongoing treatment with the same dose of VYVANSE (N=78) or switched to placebo (N=79) during the double-blind phase
Start Low, Titrate Slowly The standard titration protocol starts at 1mg/week and escalates gradually
But he said he is also concerned about the fact that, for compounders, its challenging to get the right ingredients. And, as a result, human beings are injecting themselves with versions of GLP-1 drugs meant for laboratory studies, which, Aggarwal said, could be harmful. At the end of the day, these are real humans we are taking care of, he said